Fibromyalgia ME CFS Australia Bridges & Pathways

20/10/2025

Monthly Management Workshops

09/10/2025

A team of researchers have published a paper assessing the effectiveness of the care provided for people with severe or very severe ME/CFS at a specialist clinic in Norway.

Read more about what the team found here: https://tinyurl.com/2ftvrar5

30/09/2025

CHANGE OF TIME - based on your poll feedback and suggestions, we are combining our online groups to Tuesdays at 1pm AEST (12.30 Adelaide time). Join us to connect and learn. Send you questions to bpprojects04@gmaIl.com

28/09/2025

27/09/2025

Thank you for your question? - Here is the requested diagram from our ME/CFS Chronic Care Management Model developed to support General Practices provide tailored Medicare CDM Management plans.

26/09/2025

The field of rheumatology has evolved from treating joints to tackling systemic autoimmune disease. Today, the field faces its next frontier: infection-associated chronic conditions like ME/CFS and Long COVID, or risk leaving millions in limbo.
Read more in today’s blog: “The Next Expansion: Why Rheumatology Must Prepare for Infection-Associated Chronic Conditions (IACCs)” → https://bit.ly/4mByFl3

In this post, Dr. Brayden Yellman, Medical Director at the Bateman Horne Center, shares insights shaped by years in outpatient rheumatology. He underscores both the urgency and the barriers rheumatology faces in treating patients with these conditions:

➡️ Lack of biomarkers and limited testing leave too many patients undiagnosed
➡️ Standard rheumatology drugs don’t work for IACCs, requiring new approaches
➡️ Workforce shortages and systemic pressures push the sickest into diagnostic limbo

At Bateman Horne Center, we’re equipping providers with tools to recognize and support patients with IACCs across specialities, including rheumatology. But to make this standard practice, we need your help.

💙 Support provider education today → https://bit.ly/4grlbXr

23/09/2025

Webinar for Registered Health Professionals

This is a RACGP Accredited CPD Activity - Activity ID: 1256291

Postural Orthostatic Tachycardia Syndrome (POTS) is the most common type of autonomic nervous system disorder, with increasing prevalence following the COVID-19 pandemic. It is now recognised as a dominant phenotype in Long COVID. POTS primarily affects women of childbearing age and often presents with complex, multisystem symptoms.

General practitioners and other primary health care professionals are ideally positioned to play a pivotal role in the early recognition, investigation, and management of POTS.

This webinar will:

Outline the underlying pathophysiology and common clinical features of POTS

Review key investigations and how to interpret them in the primary care setting

Discuss first-line non-pharmacological and pharmacological treatment strategies

Share insights into the lived experience of individuals with POTS to support a patient-centred approach to diagnosis and care

The webinar will be delivered by Australian POTS Foundation (APF) CEO and Founder Dr Marie-Claire Seeley and Scientific Chair of the APF Dr Celine Gallagher. They will be joined by an expert POTS cardiologist, Professor Dennis Lau and General Practitioner Dr Peter Del Fante for the Question and Answer session.

This webinar will be held via Zoom. There will be a 30 minute Question and Answer session at the end of the webinar. All questions can be submitted via the Question and Answer button.

The link to join the webinar will be sent via email to the email address you register with one day prior to the event.

Members of the Australian POTS Foundation are entitled to receive a 50% discount to attend this webinar. Further information about membership can be found here: https://potsfoundation.org.au/associate-membership

Book your ticket here: https://events.humanitix.com/diagnosis-and-management-of-postural-orthostatic-tachycardia-syndrome-pots-in-primary-care

22/09/2025

A new (small) clinical trial shows that solriamfetol reduces self-reported fatigue in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). I don't th...

19/09/2025

While there are no definitive diagnostic tests or approved treatments specific to ME/CFS, there are no shortage of interventions a clinician can make to improve patient quality of life and significantly reduce the overall symptomatic burden of ME/CFS Early accurate diagnosis and targeted management can improve health outcomes and provide records to help Australians meet Centrelink and NDIS assessments.

While there are no cures, there are a number of interventions that can help improve quality of life and reduce the the overall symptom burden of ME/CFS.